Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review(S)-5-Bromowillardiine
Discontinued Product
(S)-5-Bromowillardiine (Cat. No. 0304) has been withdrawn from sale for commercial reasons.
Description: Active isomer of (0132)
Chemical Name: (S)-(-)-a-Amino-5-bromo-3,4-dihydro-2,4-dioxo-1(2H)pyridinepropanoic acid
Biological Activity for (S)-5-Bromowillardiine
Potent AMPA receptor agonist. Also active at dorsal root C fibre kainate receptors and DRG cells.
Technical Data for (S)-5-Bromowillardiine
| M. Wt | 278.06 |
| Storage | Store at RT |
| CAS Number | 19772-78-2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for (S)-5-Bromowillardiine
Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service
Please contact Customer Service
References for (S)-5-Bromowillardiine
References are publications that support the biological activity of the product.
Hawkins et al (1995) Binding of the new radioligand (S)-[3H]-AMPA to rat synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardine. Neuropharmacology 34 405 PMID: 7566471
Patneau et al (1992) Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J.Neurosci. 12 595 PMID: 1371315
Jane et al (1991) New willardiine analogues with potent stereoselective actions of mammalian spinal neurones. Br.J.Pharmacol. 104 333P
Thompson et al (1996) Depolarising effects of certain derivatives of (S)-willardine upon in vitro neonatalrat dorsal roots. Br.J.Pharmacol. 117 331P
View Related Products by Target
Keywords: (S)-5-Bromowillardiine, (S)-5-Bromowillardiine supplier, AMPA, Receptors, 0304, Tocris Bioscience
Citations for (S)-5-Bromowillardiine
Citations are publications that use Tocris products.
Currently there are no citations for (S)-5-Bromowillardiine.
Reviews for (S)-5-Bromowillardiine
There are currently no reviews for this product. Be the first to review (S)-5-Bromowillardiine and earn rewards!
Have you used (S)-5-Bromowillardiine?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Addiction Poster
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Alzheimer's Disease Poster
Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.